STLN
The Oncology Institute, Inc.
6.30$
-0.8%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|
| – | +14.7% | +14.0% | +3.9% | +3.9% | +9.4% | – | |
| – | +17.4% | +15.0% | +1.3% | +4.1% | +8.0% | – | |
| – | +1.5% | +8.1% | +20.3% | +2.4% | +16.5% | – | |
| – | +6.0% | -6.2% | +11.0% | +0.6% | +6.1% | – | |
| – | +14.6% | -79.4% | +10.0% | +0.5% | +6.5% | – | |
| – | – | – | – | – | – | – | |
| – | -66.4% | +2.7% | -0.2% | +0.9% | -3.9% | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | -675.8% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.